Results 261 to 270 of about 305,984 (384)
Takotsubo cardiomyopathy during armed conflict: A case series
ESC Heart Failure, Volume 12, Issue 2, Page 1494-1498, April 2025.
Sharon Bruoha +13 more
wiley +1 more source
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger +15 more
wiley +1 more source
Between hope and hype: assessing artificial intelligence in cardiovascular imaging. [PDF]
Fortuni F +5 more
europepmc +1 more source
Erratum to: How do MYBPC3 mutations cause hypertrophic cardiomyopathy? [PDF]
Steven B. Marston +4 more
openalex +1 more source
Effect of atrial fibrillation ablation on myocardial function: insights from cardiac magnetic resonance feature tracking analysis [PDF]
Armbruster, M +6 more
core +1 more source
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li +12 more
wiley +1 more source
Exploration of calcium and amino acids for children with primary cardiomyopathies based on genetic characteristics. [PDF]
Jiang S +7 more
europepmc +1 more source
Occurrence of Takotsubo Cardiomyopathy after Synthetic Cannabinoid Consumption.
Denelle Mohammed
openalex +2 more sources
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao +27 more
wiley +1 more source

